Moreover, as reported above, the timing of NRF2 activation is crucial to understand its role: in cancers, it is chronically hyperactivated, whereas in normal tissue it is constantly repressed by KEAP1-dependent degradation and activated only in response to stress stimuli. Here, KEAP1 is linked to cancer.